AVENUE THERAPEUTICS, INC.
Avenue Therapeutics, Inc. (ATXI), a specialty pharmaceutical company focused on the development and commercialization of therapies for neurologic diseases, has recently filed its 10-K form for the fiscal year ended December 31, 2023. This analysis aims to dissect the filing to assess the company'...